Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings.
about
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in KoreaBasal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision makingIncorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic DiseasesHypoglycemic effect of polysaccharides with different molecular weight of Pseudostellaria heterophylla.Liraglutide as add-on therapy to insulin in type 2 diabetes mellitus: a retrospective, observational study from a daily clinical practice setting in SwitzerlandMinimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany.Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population.Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes.Treating the obese diabetic.Pharmacotherapy considerations in diabetes and obesity: setting patients up for success.Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps.Synthesis and Evaluation of a Series of Long-Acting Glucagon-Like Peptide-1 (GLP-1) Pentasaccharide Conjugates for the Treatment of Type 2 Diabetes.Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide.Pursuit of a perfect insulin.Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme.Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany.An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin.Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle.Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library.
P2860
Q26852590-A8DEF29F-8B8A-48E3-926B-ECEBEED26057Q26992979-54A11609-1709-4D1C-A8AC-67CD315C8A9FQ28069705-9354A667-126E-4409-A6BF-62F2CCF9758BQ35019127-1C20BEC7-C3DC-47B4-B8B5-85F7176B9319Q35217925-0F7F9FCD-AD94-4559-8FC2-DA3E749478D1Q35666228-27CB944C-FD02-4EC7-8369-8CFD1A4ED59EQ36498624-AD97B3DA-BA1B-46BE-98C6-255C2330CF35Q37069371-D4B066FE-C3F4-4F71-9027-88C6976D3478Q37699685-3291D5EE-C414-41DB-9FE7-0DA4F63F46B7Q38083047-E6DE8B5C-CEB1-44B9-B9D0-23852697F375Q38087696-EA4259C4-0874-49A8-A445-8617F80CD232Q38200829-3034A44C-4722-4428-B7EB-404674628527Q38246691-E9256A11-E590-4119-9124-BEE9E05542E2Q38298423-4A23DA33-6E67-4361-82CB-A476827B503CQ38299362-4F3C2354-1241-4CE4-BA94-23FE43004492Q38393753-D12ECD77-AD70-46EF-8957-E8A2FB426C9CQ38778988-64F6862A-5153-49CE-A95E-0F875D0C3983Q40529883-C635AB5A-92B1-4778-9E16-8DBDBEA82392Q41086086-355182B3-1D9C-4942-B5B4-28C19747EB7EQ47429828-CD8EB674-E8BF-4A74-B909-C6186BB0FD09Q48200213-33FADC0E-2B12-47EF-9B74-DDF3B6EDE4F4Q48251736-41E4B59C-E556-40AB-83B0-0CC4B1B9BD35
P2860
Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Combining GLP-1 receptor agoni ...... ionales and clinical findings.
@en
type
label
Combining GLP-1 receptor agoni ...... ionales and clinical findings.
@en
prefLabel
Combining GLP-1 receptor agoni ...... ionales and clinical findings.
@en
P2860
P1476
Combining GLP-1 receptor agoni ...... ionales and clinical findings.
@en
P2093
T Vilsbøll
P2860
P356
10.1111/J.1463-1326.2012.01628.X
P577
2012-06-29T00:00:00Z